Literature DB >> 28017628

Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab.

Caitlin M Burk1, Evan S Dellon2, Pamela H Steele3, Yamini V Virkud4, Mike Kulis3, A Wesley Burks3, Brian P Vickery3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28017628      PMCID： PMC5346340          DOI： 10.1016/j.jaip.2016.11.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  8 in total

1.  Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports.

Authors:  Eileen Semancik; Wael N Sayej
Journal:  Pediatr Allergy Immunol       Date:  2016-04-07       Impact factor: 6.377

2.  Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.

Authors:  Frederic Clayton; John C Fang; Gerald J Gleich; Alfredo J Lucendo; Jose M Olalla; Laura A Vinson; Amy Lowichik; Xinjian Chen; Lyska Emerson; Kristen Cox; Molly A O'Gorman; Kathryn A Peterson
Journal:  Gastroenterology       Date:  2014-06-04       Impact factor: 22.682

3.  Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease.

Authors:  Alfredo J Lucendo; Ángel Arias; Jesús González-Cervera; José Luis Yagüe-Compadre; Danila Guagnozzi; Teresa Angueira; Susana Jiménez-Contreras; Sonia González-Castillo; Benito Rodríguez-Domíngez; Livia C De Rezende; José M Tenias
Journal:  J Allergy Clin Immunol       Date:  2013-01-31       Impact factor: 10.793

Review 4.  Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis.

Authors:  Alfredo J Lucendo; Angel Arias; José M Tenias
Journal:  Ann Allergy Asthma Immunol       Date:  2014-09-10       Impact factor: 6.347

Review 5.  Peanut oral immunotherapy: is it ready for clinical practice?

Authors:  Hugh A Sampson
Journal:  J Allergy Clin Immunol Pract       Date:  2012-12-27

6.  A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

Authors:  Robert A Wood; Jennifer S Kim; Robert Lindblad; Kari Nadeau; Alice K Henning; Peter Dawson; Marshall Plaut; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2015-11-12       Impact factor: 10.793

7.  Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.

Authors:  Kari C Nadeau; Lynda C Schneider; Lisa Hoyte; Irene Borras; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

8.  Omalizumab facilitates rapid oral desensitization for peanut allergy.

Authors:  Andrew J MacGinnitie; Rima Rachid; Hana Gragg; Sara V Little; Paul Lakin; Antonella Cianferoni; Jennifer Heimall; Melanie Makhija; Rachel Robison; R Sharon Chinthrajah; John Lee; Jennifer Lebovidge; Tina Dominguez; Courtney Rooney; Megan Ott Lewis; Jennifer Koss; Elizabeth Burke-Roberts; Kimberly Chin; Tanya Logvinenko; Jacqueline A Pongracic; Dale T Umetsu; Jonathan Spergel; Kari C Nadeau; Lynda C Schneider
Journal:  J Allergy Clin Immunol       Date:  2016-09-05       Impact factor: 10.793
  8 in total
  12 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

Review 2.  Pathophysiology of Eosinophilic Esophagitis.

Authors:  Kelly M O'Shea; Seema S Aceves; Evan S Dellon; Sandeep K Gupta; Jonathan M Spergel; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 22.682

Review 3.  Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.

Authors:  Yamini V Virkud; Julie Wang; Wayne G Shreffler
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

4.  Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis.

Authors:  Ting Wen; Bruce J Aronow; Yrina Rochman; Mark Rochman; Kiran Kc; Phil J Dexheimer; Philip Putnam; Vincent Mukkada; Heather Foote; Kira Rehn; Sam Darko; Daniel Douek; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2019-04-08       Impact factor: 14.808

5.  Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis.

Authors:  Duncan M Morgan; Bert Ruiter; Neal P Smith; Ang A Tu; Brinda Monian; Brandon E Stone; Navneet Virk-Hundal; Qian Yuan; Wayne G Shreffler; J Christopher Love
Journal:  Sci Immunol       Date:  2021-08-13

6.  Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Dana Tupa; Wenming Zhang; Matthew A Rank; Hirohito Kita; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Scott D Boyd; Mindy Tsai; Holden Maecker; Monali Manohar; Stephen J Galli; Kari C Nadeau; R Sharon Chinthrajah
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

Review 7.  Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.

Authors:  Alfred D Doyle; Mia Y Masuda; Hirohito Kita; Benjamin L Wright
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

Review 8.  An Overview of the Relevance of IgG4 Antibodies in Allergic Disease with a Focus on Food Allergens.

Authors:  Thomas A E Platts-Mills; Behnam Keshavarz; Jeffrey M Wilson; Rung-Chi Li; Peter W Heymann; Diane R Gold; Emily C McGowan; Elizabeth A Erwin
Journal:  Children (Basel)       Date:  2021-05-20

9.  Oral immunotherapy for multiple foods in a pediatric allergy clinic setting.

Authors:  Amy A Eapen; William J Lavery; Jaweriah S Siddiqui; Michelle B Lierl
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-06       Impact factor: 6.347

Review 10.  Eosinophilic Esophagitis as a Side Effect of Food Oral Immunotherapy.

Authors:  Antonella Cianferoni
Journal:  Medicina (Kaunas)       Date:  2020-11-16       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.